Philip Morris International (PM) Q3 2026 earnings review
Philip Morris profit rises on cigarettes while smoke-free sales slow
Philip Morris earned more this quarter because cigarette prices went up, while its smoke-free business grew slowly. Revenue rose 7% excluding currency and operating profit more than 10%, but international smoke-free sales grew only 3%. Chief executive Jacek Olczak pointed to "the exceptional results of our combustible business". The full-year plan for profit excluding currency did not move, so by our math higher energy costs and ZYN spending will absorb this quarter's extra profit in the fourth quarter.
| Sales growth, excluding currency and acquisitions | +7.1% reported +5.5% |
|---|---|
| Profit per share, excluding one-offs | $2.36 +5.4% from a year ago; reported $2.12, down 4.9% |
| Smoke-free share of revenue | 40.4% 41.0% a year ago |
| Full-year profit outlook, excluding one-offs and currency | Unchanged $8.11–8.26 per share; by our math $1.79–1.94 left for Q4 |
⚖️ Verdict: ⚪ Neutral
The story is unchanged, because the quarter's good news and its bad news cancelled out. IQOS consumer sales sped up again and ZYN gained share in the United States, so the two biggest worries eased a little. The bad news: the company kept its full-year profit plan excluding currency unchanged even after beating its own third-quarter target, so the fourth quarter now has less room than it did three months ago. One caution: a beat the company does not carry into its plan says the costs ahead are real, not that the plan was cautious.
The question now is whether international smoke-free sales speed up again in the fourth quarter, as the outlook assumes. Either shipments catch up with consumer purchases, which grew 7% this quarter, and the segment returns to high-single-digit growth; or the hangover from Japanese tax buying and the Polish flavour ban keep it in low single digits. The fourth-quarter segment figures in February will tell.
🐂 Bull Case
Cigarettes Grew Again, at Higher Prices
Philip Morris still earns most of its money from cigarettes, and this quarter they did the heavy lifting. The company shipped 158 billion cigarettes, the same as a year ago, while raising prices 8.9%. The growth came from Turkey, Indonesia and Egypt, where smoke-free products are banned or barely sold, so these sales do not compete with IQOS.
Part of the gain was a one-time item. The company said the quarter "benefited from the favorable restructuring of distribution terms in certain markets, which is not expected to recur at the same level in future quarters". It gave no amount, so the underlying pricing is somewhat below the headline figure.
- Cigarette sales excluding currency: up 7.8% from a year ago
- Gross margin on cigarettes: 68.5%, up 1.3 percentage points
- Marlboro share of the cigarette market: 11.4%, a record
- Full-year cigarette volume outlook: a decline near 1%, from 2–3% before
This matters because cigarette profit pays for the smoke-free investments, and the company has raised its cigarette volume outlook twice this year. Chief executive Jacek Olczak says the group is "firmly on track for a sixth consecutive year of volume growth". But the gains sit in low-price markets, so the company said geographic mix ate part of the pricing.
What to watch: the cigarette gross margin in the fourth quarter, once the distribution-terms benefit fades and higher energy costs land. A reading near 68% would mean pricing alone carries the segment.
Costs Grew Slower Than Sales
Operating profit rose faster than revenue because every large cost line grew more slowly than sales. The cost of making the products fell to 31.3% of revenue from 32.1%, helped by cigarette pricing. Marketing, administration and research costs, excluding one-off items, fell to 24.0% of revenue from 24.5%, even with more spending on ZYN in the United States.
The operating margin excluding one-offs reached 44.7%, 1.6 points higher than a year ago. The outlook does not expect that pace to last: the company now sees operating income growth excluding currency in the lower half of its 7–9% range, because of energy costs and ZYN spending. By our math that leaves the fourth quarter growing about 5–9%.
What to watch: the fourth-quarter operating margin excluding one-offs against 35.9% a year ago. A reading above that would mean the energy and ZYN costs are smaller than the plan assumes.
IQOS Grows Faster Outside Japan and Europe
IQOS is the device that heats tobacco instead of burning it, and Philip Morris tracks its progress through adjusted in-market sales, the closest measure of what consumers actually buy. Those sales grew 7.1% this quarter, after 5.1% in the second quarter, and 10% once Japan and Poland are left out.
- Outside Europe and Japan: up 12.7%, with share gains in Riyadh, Kuala Lumpur, Mexico City, Jakarta and Taipei
- Europe: up 6.0%, or about 8% excluding Poland, where a flavour ban took effect in January
- VEEV e-vapor shipments: up 61.6%, with a launch in South Korea in August
- ZYN pouches outside the U.S.: up 20.6%, now sold in 62 markets
This matters because Japan, the largest IQOS market, is slowing under tax increases, so the company needs other markets to carry growth. It calls this "the increasing geographic diversification of IQOS". Shipments grew only 1.5%, but the company said that was timing between quarters, and consumer sales are the better measure.
What to watch: fourth-quarter IQOS consumer sales growth excluding Japan and Poland. Another double-digit reading would mean the newer markets can offset Japan through 2027.
🐻 Bear Case
Smoke-Free Sales Barely Grew This Quarter
Philip Morris describes itself as a smoke-free champion, and smoke-free products brought in 40.4% of revenue this quarter. A year ago the share was 41.0%, so cigarettes gained ground. International smoke-free revenue rose 3.4% excluding currency, and only 0.7% as reported. Cigarette revenue on the same basis rose 7.8%.
The company blamed "a challenging HTU comparison due to the phasing of shipments between periods, notably in Japan". Shipments of heated tobacco sticks grew 1.5% while consumer purchases grew 7.1%, so stock held by distributors fell. That explanation holds for one quarter, but the gap must close for the full-year plan to work.
The outlook now rests on "a fourth-quarter reacceleration in international smoke-free". By our math, the full-year revenue range leaves the fourth quarter growing about 2–10% excluding currency, and the company points to the upper half. One quarter of shipments catching up with consumers would deliver that.
What to watch: international smoke-free revenue growth excluding currency in the fourth quarter. A reading above 8% confirms the timing story; another low-single-digit quarter means consumer demand, not shipments, is the problem.
Japan's Tax Increases Keep Slowing IQOS at Home
Japan is the largest market for IQOS, and the government raised the tax on heated tobacco twice this year, on April 1 and October 1. Consumer purchases of the company's heated sticks grew 3.4% in the quarter, or 1.3% once the company strips out buying ahead of the October increase.
The company said this was "broadly in line with our expectations as consumers adjust", and IQOS held a 68% share of the category. SENTIA, its cheaper stick, is catching price-sensitive users. But the fourth quarter starts with the hangover from the October purchases, and the schedule of tax steps runs to 2029.
What to watch: Japan consumer sales growth in the fourth quarter. A reading near zero would be the hangover; a decline would mean smokers are leaving the category, not just switching brands.
ZYN Sells More, but Its U.S. Profit Stays Flat
ZYN is the nicotine pouch Philip Morris acquired with Swedish Match, and the United States is its main market. Shipments grew 4.2% to 3.2 billion pouches against a quarter last year that included a large promotion, and Nielsen data show ZYN's share of the category rose by over one point between June and September.
Revenue grew 22.7%, mainly because last year's promotions had cut prices. Profit did not follow. The segment's operating income excluding one-offs rose 1.5% excluding currency, to $171 million, because of "a significant increase in commercial investments to support the expansion of our ZYN portfolio".
The spending rises again in the fourth quarter, with a bigger brand campaign and a move of most flagship products to 20-pouch cans from 15. The company says the change is "designed to align the value proposition across the portfolio and optimize ZYN's price premium", which reads as a lower price per pouch. The FDA also authorised 11 more ZYN ULTRA variants in August.
What to watch: U.S. segment operating income in the fourth quarter. A loss would show the cost of the can change; profit near this quarter's level would mean the price adjustment is smaller than it sounds.
Risks this quarter didn't answer
Seven standing concerns got no new numbers in the press release. Most of them live in the quarterly filing, which the company says it will file in the coming days, so the readings below are the ones to look for there.
- Russia: no figures; the filing's asset and cash-by-country tables will show whether the exposure has changed.
- Ukraine: the company cited "the impact of strikes on our supply chain and logistics infrastructure in certain locations" and a cost to operating income this year, without an amount.
- ZYN product-liability case: trial scheduled for December 7; the class-certification ruling would move the risk either way.
- European tobacco rules: the revision proposal is due by year-end; any heated-tobacco or pouch provisions would be the reading.
- Segment operating income: still shown only for International versus U.S.; a split between smoke-free and cigarettes would settle which business earns the margin.
- Japanese patent actions against the TEREA importer: no update; a customs seizure would be the reading.
- Indonesian free-float sell-down to 12.5% by March 2027: no mechanism or timing yet.
👓 Other Themes
Energy Costs Rise With the Middle East Conflict
The company reported "energy-related inflation driving incremental cost pressures in the third quarter" and expects a slightly larger effect in the fourth quarter as more input price increases take effect. Costs cut $104 million from gross profit this quarter. Together with the ZYN spending, this is why the operating income outlook now leans to the lower half of its range.
A New Finance Chief Hosts the Call
Massimo Andolina hosted his first results call as Group Chief Financial Officer, after moving from regional president for Europe in August; Emmanuel Babeau has left after six years. The release carries no comment from him, so his approach to the outlook and to segment reporting remains unread until the filing and the call transcript arrive.
💲 Other KPIs
Debt is shrinking relative to cash profit: 2.17 times, from 2.35 in June and 2.53 at year-end. Net debt is $40.9 billion, $3.1 billion less than in December, with no share buybacks and the dividend taking about $2.3 billion a quarter at the old rate. The year-end target is close to 2.0 times.
Cash from operations rose 20% from a year ago, and 39% over nine months to $10.4 billion. Profit and working capital both helped, though the release does not separate them. Nine months already cover 77% of the full-year outlook, which the company left at about $13.5 billion.
Raised 8.8%, after 8.9% a year ago, to an annual $6.40. By our math that costs about $10 billion a year on 1.56 billion shares. With no buybacks planned, the dividend is the only cash return while the company pays down debt.
Fell 4.9% even though underlying profit rose, because items below operating income went the other way. The value of share investments in India and Sri Lanka dropped, a $0.06 charge against a $0.07 gain last year. A Dutch pension buy-out cost $0.04, and the tax rate rose to 21.5% from 18.7%.
🔮 Guidance
Raised, but only for currency. The plan has profit per share excluding one-offs rising 9.9–11.9% this year, with currency now adding 18 cents instead of 15. By our math that leaves $1.77–1.92 for the fourth quarter, 4–13% above a year ago. Three moves since February, all currency: −2 cents, −10 cents, +3 cents at the middle of the range.
Unchanged for a fourth quarter in a row, so profit excluding one-offs and currency still grows 7.5–9.5%. By our math the fourth quarter gets $1.79–1.94, about 7 cents less at the middle than the plan implied three months ago, because the company did not add this quarter's beat to the year. It has beaten its quarterly target three times this year by about 7% on average; if the pattern holds, the year lands near $8.32, above the range.
Cut by 8 cents at the middle, entirely on one-off charges. The write-down of share investments in India and Sri Lanka grew to 22 cents from 16, and the company added a 4-cent Dutch pension buy-out loss. Underlying profit did not move.
Raised. The company now expects total volume to grow this year, from "broadly stable to slightly growing" before, because cigarette shipments are falling only about 1% instead of 2–3%. Nine-month total volume is up 0.5%, so the fourth quarter needs no acceleration. Second upgrade of the cigarette line this year.
Unchanged, with a new lean to the upper half. The plan still has sales growing 5–7% this year excluding currency and acquisitions. By our math, nine-month growth of 5.9% leaves the fourth quarter at about 2–10%. The upper-half lean points to the higher end of that, close to this quarter's pace, and rests on "a fourth-quarter reacceleration in international smoke-free".
Unchanged, with a new lean to the lower half. The plan has operating income growing 7–9% this year excluding currency and acquisitions. By our math, nine-month growth of 7.7% leaves the fourth quarter at about 5–13%, and the lower-half lean means 5–9%, down from 10.5% this quarter. The company cites energy costs and the U.S. investment step-up.
Unchanged. The add-back is $0.37 after nine months, so the fourth quarter carries 13 cents, the same as each quarter this year.
New as a written assumption. Net interest expense was $199 million this quarter, down from $230 million, and $679 million over nine months against $748 million. The assumption adds no number; a full year near last year's level would mean a higher fourth-quarter charge than this quarter's, by our math.
Unchanged. The rate was 21.5% this quarter and 20.9% over nine months by our math, so landing on plan means a fourth-quarter rate above the nine-month average.
Unchanged. By our math, nine-month cash flow of $10.4 billion leaves about $3.1 billion for the fourth quarter, against $4.7 billion a year earlier, a drop of about 35%. The company keeps the figure "subject to year-end working capital requirements", so either the plan is cautious or it expects working capital to absorb cash in the fourth quarter.
Unchanged for a fourth quarter, mostly for smoke-free factories. The release gives no nine-month spending figure.
Unchanged. The ratio is 2.17 at September 30. By our math, reaching 2.0 on today's rolling cash profit needs net debt about $3.2 billion lower, while the fourth-quarter cash flow in the plan barely covers the dividend. The target therefore depends on fourth-quarter profit growth and currency, which the company notes by saying "at prevailing exchange rates".
Unchanged. No buybacks this year; the diluted share count is 1,560 million, up 0.1% from a year ago.
❓ Key Questions
How large was the one-off benefit in cigarette revenue?
The company said restructured distribution terms helped cigarette sales this quarter and will not repeat at the same level. Without an amount, readers cannot tell how much of the 7.8% growth excluding currency is underlying pricing.
How much will the fourth-quarter ZYN investment cost?
The company plans a bigger brand campaign, a move to 20-pouch cans and transitional support programmes, but gives no dollar figure. The size decides whether the U.S. segment posts a loss and how much of the operating income range it absorbs.
Why does the cash flow outlook imply a weak fourth quarter?
By our math the unchanged $13.5 billion plan leaves about $3.1 billion for the fourth quarter, a third below last year. A working-capital reversal would explain it; a cautious plan would mean the leverage target is closer than it looks.
What do the two international segments earn after marketing costs?
Operating income is shown only for International versus U.S., so the margin of smoke-free products against cigarettes is not visible. A split would settle whether the smoke-free business earns the premium margin the company claims for it.
How much of ZYN ULTRA's growth is new demand?
ZYN's category share rose by over one point between June and September, but the company has not said how much of ZYN ULTRA's volume comes from new users rather than from its own flagship pouches.